Testimony and Comments

IPO Comments to the China National Medical Products Administration Re: Feedback on the Regulations for the Implementation of the Drug Administration Law of the People’s Republic of China

IPO Comments to the China National Medical Products Administration Re: [...]

By Hannah Denny|2022-06-13T07:46:33-04:00June 9th, 2022|Testimony and Comments|Comments Off

IPO Comments in Response to EU Call for Evidence Regarding [...]

By Hannah Denny|2022-06-01T11:05:56-04:00April 29th, 2022|Testimony and Comments|Comments Off

IPO and Other IP Associations Joint Statement on Tentative TRIPS [...]

By Hannah Denny|2022-03-24T08:58:06-04:00March 24th, 2022|Testimony and Comments|Comments Off

By Hannah Denny|2022-03-08T23:37:23-05:00March 8th, 2022|Testimony and Comments|Comments Off

IPO and AIPLA Joint Letter Urging Confirmation of the USPTO [...]

By Hannah Denny|2022-02-28T08:18:02-05:00February 24th, 2022|Testimony and Comments|Comments Off

IPO Letter to PPAC re: Design Patents MPEP Section and [...]

By Hannah Denny|2022-06-01T11:02:53-04:00February 16th, 2022|Testimony and Comments|Comments Off

IPO Comments Regarding the USPTO’s Notice of Proposed Rulemaking on [...]

By Hannah Denny|2022-02-15T10:18:18-05:00February 14th, 2022|Testimony and Comments|Comments Off

By Hannah Denny|2022-02-01T12:51:48-05:00January 31st, 2022|Testimony and Comments|Comments Off

By Hannah Denny|2022-02-08T15:11:27-05:00January 20th, 2022|Testimony and Comments|Comments Off

By Hannah Denny|2022-01-25T10:26:46-05:00January 14th, 2022|Testimony and Comments|Comments Off